Find your next paid study

VA Greater Los Angeles Healthcare SystemNCT07031245

~$10 – $1,125

Actual pay is set by the research site.

Phase 2

Assessment of Biomarker-Guided Calcineurin Inhibitor (CNI) Substitution In Kidney Transplantation (RTB-015)

800 adult first time kidney transplant recipients will be enrolled in the Observational Study and followed to evaluate their Human Leukocyte Antigen (HLA)-DR/D…

Kidney Transplant

National Institute of Allergy and Infectious Diseases (NIAID)NCT05917522

~$75 – $1,800

Actual pay is set by the research site.

Penn Sjögren's International Clinical Collaborative Alliance (SICCA) Follow-up Study

This study will involve the collection of follow-up data for patients who previously participated in the Sjogren's International Clinical Collaborative Allianc…

Dry EyeSjogren's Syndrome

University of PennsylvaniaNCT05056012

Actual pay is set by the research site.

Phase 2

Phase 2 Study of Combination Pirtobrutinib (LOXO-305) and Venetoclax in CLL Patients With Resistance to Covalent BTKi

This phase II trial tests how well pirtobrutinib (LOXO-305) and venetoclax works in treating patients with chronic lymphocytic leukemia (CLL) or small lymphocy…

Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma

Clear Cell Renal Cell Carcinoma

~$75 – $3,000

Actual pay is set by the research site.

Kerry RogersNCT06466122

Phase 1

A Phase 1 Study Of LNK001 (Dual ENPP3/CAIX AND-gate CAR T Cell Therapy) In Advanced Or Metastatic Clear Cell Renal Cell Carcinoma

There are 2 parts to this clinical research study: Part 1 (Dose Escalation) and Part 2 (Dose Expansion). The goal of Part 1 is to find the recommended dose of…

M.D. Anderson Cancer CenterNCT07564232

~$150 – $3,000

Actual pay is set by the research site.

Phase 1

A Phase 0/I/II Study of the Cyclin-Dependent Kinase(CDK)4/6 Inhibitor Abemaciclib for Neurofibromatosis Type 1 (NF1) Related Atypical Neurofibromas

Background: NF1 is a genetic disease that causes tumors called atypical neurofibromas. These tumors, which arise from nerves, can cause serious medical proble…

Neurofibromatosis 1

National Cancer Institute (NCI)NCT04750928

~$150 – $2,700

Actual pay is set by the research site.

Neural Correlates of Real World Spatial Navigation in Humans

The purpose of this study is to understand the neural mechanisms that support real world spatial navigation in humans using deep brain recordings and stimulati…

Memory, Delayed

Duke UniversityNCT04874220

Actual pay is set by the research site.

Phase 1

Perioperative Nutritional Optimization in Patients With Critical Limb Ischemia

A prospective pilot study examining nutritional supplements among vascular surgery patients with Critical Limb Ischemia (CLI). CLI patients have a high rate of…

Critical Limb IschemiaMalnutritionNutritional Supplements

Boston Medical CenterNCT03529019

~$150 – $3,000

Actual pay is set by the research site.

Comparing Standard of Care Versus a Technology-Based Approach To Reduce Postpartum Emergency Department Visits

The goal of the proposed research is to test the comparative effectiveness of AIM safety bundles for post-partum women delivered in-person vs. via text/phone t…

Postpartum Complication

Medical University of South CarolinaNCT06273436

Actual pay is set by the research site.

Differentiated Thyroid Cancer (DTC)Papillary Thyroid MicrocarcinomaPapillary Thyroid Carcinoma

Efficacy of a Patient-facing Decision Aid in Reducing Decision Anxiety and Improving Decision Readiness in Low Risk Thyroid Cancer

Low-risk thyroid cancer grows very slowly. More than 99% of patients with this cancer survive for at least 5 years. There are 3 main treatment options: remove …

University of Maryland, BaltimoreNCT07536412

Actual pay is set by the research site.

Testing a Behavioral Weight Loss Intervention for Emerging Adults Implemented Within College Health Service Centers

This pilot randomized controlled trial will examine a behavioral weight loss intervention that uses a "small change" approach fro emerging adult college studen…

Obesity and Overweight

The Miriam HospitalNCT06994923

Actual pay is set by the research site.

Phase 2

Phase 2 Trial of Zipalertinib in Patients With Resectable Non-Small Cell Lung Cancer With EGFR Exon 20 Insertion or Uncommon/Compound Mutations

This phase II trial tests how well zipalertinib with carboplatin and pemetrexed works in treating stage II-IIIB non small cell lung cancer. that can be removed…

Lung Non-Squamous Non-Small Cell Carcinoma